A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
Title:
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
Author:
Paik, Paul K. Rudin, Charles M. Pietanza, Maria C. Brown, Andrew Rizvi, Naiyer A. Takebe, Naoko Travis, William James, Leonard Ginsberg, Michelle S. Juergens, Rosalyn Markus, Susan Tyson, Leslie Subzwari, Sara Kris, Mark G. Krug, Lee M.